Bexarotene and Hypopituitarism
ABSTRACT: Objective: Bexarotene is currently approved for treatment of cutaneous T-cell lymphoma and is also under investigation for other cancers such as lung, breast, and thyroid cancer. We recently reported a patient with mycosis fungoides treated with bexarotene. The treatment induced hypopituit...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2015-01-01
|
| Series: | AACE Clinical Case Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2376060520302522 |